Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2021-10, Vol.106 (10), p.2749-2753
Hauptverfasser:	Dlouhy, Ivan, Armengol, Marc, Recasens-Zorzo, Clara, Ribeiro, Marcelo L, Pérez-Galán, Patricia, Bosch, Francesc, López-Guillermo, Armando, Roué, Gaël
Format:	Artikel
Sprache:	eng
Schlagworte:	B-Lymphocyte Subsets - metabolism Humans Interleukin-1 Receptor-Associated Kinases - metabolism Letters to the Editor Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - genetics Mutation Myeloid Differentiation Factor 88 - genetics Myeloid Differentiation Factor 88 - metabolism NF-kappa B - genetics NF-kappa B - metabolism Receptors, Interleukin-1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!